Crossmark

Microbiome for Mars: surveying microbiome connections to healthcare with implications for long-duration human spaceflight, virtual workshop, July 13, 2020

Crossref DOI link: https://doi.org/10.1186/s40168-020-00951-5

Published Online: 2021-01-04

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

LaPelusa, Michael

Donoviel, Dorit

Branzini, Sergio E.

Carlson, Paul E. Jr

Culler, Stephanie

Cheema, Amrita K.

Kaddurah-Daouk, Rima

Kelly, Denise

de Cremoux, Isabelle

Knight, Rob

Krajmalnik-Brown, Rosa

Mayo, Stephen L.

Mazmanian, Sarkis K.

Mayer, Emeran A.

Petrosino, Joseph F.

Garrison, Keith https://orcid.org/0000-0002-7966-8833
Funding

Funding for this research was provided by:

Translational Research Institute for Space Health (NNX16AO69A)
License Information

Text and Data Mining valid from 2021-01-04

Version of Record valid from 2021-01-04
More Information

Article History

Received: 19 October 2020

Accepted: 6 December 2020

First Online: 4 January 2021

Ethics approval and consent to participate

: Not applicable

: Not applicable

: SC declares financial interests in Persephone Biosciences, Inc. DK and IC declare financial interests in Seventure Partners. RKB received research funding from Crestovo/Finch Therapeutics. SKM declares financial interests in Axial Biotherapeutics, Inc. EAM is a scientific advisory board member of Danone, Axial Biotherapeutics, Viome, Amare, Mahana Therapeutics, Pendulum, Bloom Biosciences, and APC Microbiome Ireland. The remaining authors declare that they have no competing interests.

Document is current

Any future updates will be listed below